WEB予約
LINE予約
肥満症

Jardiance (generic name: empagliflozin) is a class of diabetes medication called an SGLT2 inhibitor that works by excreting excess blood sugar through urine. Because it eliminates roughly 200 kcal per day (about 6,000 kcal per month) of glucose, it has recently drawn attention as a medical weight loss option. In this article, the medical team at Men’s Care Clinic explains – based on package inserts and Japanese and international clinical trial data – whether Jardiance truly causes weight loss, whether its side effects are safe, and how it should be taken, including contraindications.

Table of Contents
“I love carbs and can’t quit them,” “I can’t stick to dietary restrictions,” “I don’t have time to exercise” – for men who feel this way, the SGLT2 inhibitor Jardiance (empagliflozin) has emerged as a notable medical weight loss option.
Jardiance was originally developed as a treatment for type 2 diabetes mellitus, but its mechanism of action – excreting excess blood glucose through urine – effectively eliminates a portion of caloric intake from the body, which is why it is now also prescribed as a medical weight loss agent in self-pay clinical settings.
At the same time, many people ask: “Does Jardiance really cause weight loss?” “Are the side effects scary?” “How is it different from Mounjaro or Rybelsus?” In this article, the Men’s Care Clinic medical team explains Jardiance’s role in obesity and medical weight loss, the mechanism behind its effects, side effects, and a comparison with Mounjaro and Rybelsus.


Jardiance (brand name: Jardiance, generic name: empagliflozin) is an oral antihyperglycemic agent jointly marketed by Nippon Boehringer Ingelheim and Eli Lilly Japan. It was approved in Japan as a treatment for type 2 diabetes mellitus in 2014, and indications for chronic heart failure and chronic kidney disease have since been added.
Jardiance is classified as an SGLT2 inhibitor. It blocks the action of SGLT2 (sodium-glucose cotransporter 2), a protein in the proximal tubule of the kidney, suppressing glucose reabsorption into urine and thus excreting excess sugar through urine.
Normally, glucose from food is absorbed in the small intestine and enters the bloodstream. Blood glucose is then filtered into urine by the kidneys, but nearly all of it is reabsorbed by SGLT2 and returned to the bloodstream.
Jardiance selectively inhibits SGLT2, so the glucose that would normally be reabsorbed is instead excreted through urine. The amount of glucose excreted per day is approximately 50-80 g (about 200-320 kcal), which adds up to roughly 6,000 kcal per month.
Burning 1 kg of body fat requires roughly 7,000-7,200 kcal, so theoretically, simply continuing Jardiance could be expected to result in about 0.8-1 kg of fat loss per month. This is why Jardiance is sometimes called a “glucose-excretion weight loss drug.”
Medical weight loss drugs broadly fall into two categories of approach.
In other words, Jardiance is a drug based on the idea of “eating, but excreting glucose from the body” rather than “eating less.” For people who say “I love carbs and can’t quit,” or “the stress of dieting always breaks me,” Jardiance’s approach tends to fit psychologically.
Another option, the herbal medicine Bofutsushosan, works by promoting bowel movement and improving metabolism, and differs in that it does not directly excrete glucose.


The biggest concern of those searching for “Jardiance weight loss” or “does empagliflozin help you lose weight” is “how much weight will I actually lose?” The short answer: continuing Jardiance can be expected to produce about 2-6 kg of weight loss.
In Boehringer Ingelheim’s Phase III international study, patients taking empagliflozin 25 mg for 24 weeks achieved an average 2.15 kg weight reduction compared with placebo. In long-term studies (76-90 weeks), even greater weight loss has been observed.
Weight loss with Jardiance typically progresses gradually over several months. Based on clinical trial data and real-world reports, the following estimates are commonly cited.
| Duration | Approximate weight loss | Notes |
|---|---|---|
| 1 month | About 0.5-1 kg | Early-stage loss includes water reduction from diuretic effect |
| 3 months | About 2-3 kg | Fat loss becomes the main driver. Watch for constipation and dehydration |
| 6 months | About 3-5 kg | Combining diet and exercise stabilizes results |
| 12 months | About 4-6 kg | Average reported in long-term studies. Plateau (stagnation) becomes more likely |
*Weight loss varies by individual; meal volume, exercise, baseline weight, and lifestyle significantly affect results. The table represents “Jardiance monotherapy estimates” and does not guarantee any outcome.
Because Jardiance is a “glucose-excreting drug,” people who consume more glucose (carbohydrates) tend to feel its effects more strongly. Specifically, the following individuals are good candidates.
Conversely, people who already eat very little carbohydrate (such as those on low-carb or ketogenic diets) excrete less glucose through Jardiance, so weight loss effects tend to be smaller.
The 2015 large-scale clinical trial “EMPA-REG OUTCOME” reported that Jardiance reduced cardiovascular mortality risk by 38%, drawing global attention. Following this, additional indications were added beyond type 2 diabetes:
In other words, Jardiance is not just a “weight loss drug.” It has the potential to comprehensively reduce metabolic and cardiovascular risks associated with obesity. This unique strength sets it apart from Mounjaro and Rybelsus.


How to take Jardiance is very simple: “once daily, before or after breakfast, with water or lukewarm water.” The dosage and timing are essentially the same whether the goal is diabetes treatment or medical weight loss.
Jardiance has roughly the same absorption with or without food, so either before or after meals is fine, but most clinics recommend “after breakfast” to help prevent missed doses.
The Jardiance strengths approved in Japan are 10 mg and 25 mg.
| Dose | Estimated daily glucose excretion | Recommended for |
|---|---|---|
| 10 mg | About 50-60 g (about 200-240 kcal) | First-time users / those concerned about side effects / older adults / those with mildly reduced kidney function |
| 25 mg | About 70-80 g (about 280-320 kcal) | Those who feel 10 mg is insufficient / those wanting more decisive weight loss / those who also want better blood glucose control |
In most cases, the safest approach is to start at 10 mg, then increase to 25 mg as needed based on response and side effects. Do not increase the dose on your own; always follow your doctor’s instructions.


Jardiance is a relatively safe drug, but several side effects specific to SGLT2 inhibitors are known. Below we explain the points people most commonly search for under “Jardiance side effects,” along with frequencies, symptoms, and how to handle them.
The bottom line: most side effects are mild and temporary, and can be prevented or managed with proper hydration and use under medical supervision.
| Side effect | Frequency | Symptoms / management |
|---|---|---|
| Urinary tract infection (UTI) | About 3-8% | Painful urination, frequent urination, residual urine sensation. Manage with hydration, hygiene, and antibiotics. |
| Genital infection (balanoposthitis, candidiasis) | About 2-4% | Itching and redness in the genital area. For men, prepuce hygiene is key to prevention. |
| Frequent urination / polyuria | About 3-5% | Water is excreted along with glucose. Most common in the early treatment period. |
| Dry mouth / dehydration | About 2-4% | Preventable with 1.5-2 L of fluid intake per day. |
| Dizziness / lightheadedness | About 1-2% | Caused by lower blood pressure. Avoid standing up suddenly. |
| Constipation | About 1-3% | Manage with fluid and dietary fiber intake. |
These are the main adverse effects reported in the package insert and Japan’s post-marketing surveillance. Most appear within the first 1-2 months of treatment and tend to ease as the body adapts.
Although rare, the following serious adverse events have been reported. If any of these symptoms occur, stop the medication immediately and seek medical care.
While these are classified as “serious,” their frequency is very low when fluid intake is adequate and the medication is used under medical supervision.
The package insert lists the following as contraindicated or requiring caution:
Use with diuretics, antihypertensives, insulin, and SU drugs requires particular caution. Always tell your doctor about every medication you are taking, including over-the-counter drugs.


Jardiance is not a universal weight loss drug. It suits some people and not others depending on their constitution and lifestyle, so it is important to evaluate calmly whether it is right for you.


Let’s compare the three leading medical weight loss drugs: Jardiance (SGLT2 inhibitor), Mounjaro (GLP-1/GIP receptor agonist), and Rybelsus (oral GLP-1 receptor agonist). Their mechanisms of action differ, so the right candidate for each varies.
| Comparison item | Jardiance | Mounjaro | Rybelsus |
|---|---|---|---|
| Class | SGLT2 inhibitor | GLP-1/GIP receptor agonist | GLP-1 receptor agonist |
| Action | Excretes glucose through urine | Suppresses appetite + delays gastric emptying | Suppresses appetite + delays gastric emptying |
| Form | Oral tablet | Injection (weekly) | Oral tablet (daily) |
| Estimated weight loss (6 months) | About 3-5 kg | About 8-15 kg | About 4-8 kg |
| Best for | People who love carbs | People with strong appetite / wanting big weight loss | People avoiding injections who also want appetite suppression |
| Common side effects | UTI, dehydration | Nausea, constipation | Nausea, constipation |
| Additional benefits | Cardiovascular and renal protection | Improved blood glucose | Improved blood glucose |
*For details, see each product page: Mounjaro effects and side effects / Rybelsus effects and side effects / Bofutsushosan effects
Because Jardiance and Mounjaro/Rybelsus reduce weight through different mechanisms, they can be combined under a doctor’s judgment. In the diabetes field, the combination of “SGLT2 inhibitor + GLP-1 receptor agonist” has been reported to produce additive or synergistic weight loss effects.
However, when combining these drugs in a self-pay medical weight loss setting, the following risks must be fully understood and discussed with your doctor:
Combining medications simply “to get bigger weight loss” is not recommended. The basic approach is to start with one drug, observe response and side effects, then consider combining if needed. From the perspective of medical management of obesity, lifestyle improvement is a prerequisite either way.


At Men’s Care Clinic, we offer Jardiance, Mounjaro, Rybelsus, and Bofutsushosan as medical weight loss options. After interview and exam, our doctor recommends the most appropriate medication for each patient.
Online consultation is available from your first visit, so even busy patients or those who prefer remote care can receive a consultation and prescription from home. Medications are shipped in discreet packaging that doesn’t reveal the contents.
Jardiance is a prescription-only medication and is not sold over the counter at pharmacies or drug stores. Personal import via overseas mail order is technically legal, but because of the following risks, we strongly recommend obtaining it through a medical institution:
For medical weight loss, “doing it under a doctor’s management” is the key to balancing safety and effectiveness. The Men’s Care Clinic medical team provides ongoing support.


To get the most out of Jardiance, don’t rely solely on the drug; review your diet and exercise habits in parallel. Even though it excretes 200-320 kcal of glucose per day, ongoing overeating can easily wipe out that benefit.
Below, the medical team summarizes diet and lifestyle points to keep in mind during Jardiance treatment, based on real clinical experience.
While taking Jardiance, the diet principle is “don’t drastically cut carbs; choose them and balance the amount.” Aiming for zero carbohydrates raises ketoacidosis risk, so avoid extreme low-carb practices.
By “balancing quality and quantity” instead of cutting carbs entirely, you can work synergistically with Jardiance’s glucose-excretion effect.
Jardiance’s weight loss effect can be amplified by exercise. That said, you don’t need to start with intense workouts. The trick to staying consistent is choosing exercise you can sustain comfortably.
If you don’t enjoy exercise, start with the goal of “walking 8,000 steps a day.”
Sleep and stress are often overlooked. When sleep deprivation continues, ghrelin (a hormone that increases appetite) rises, while leptin (the satiety hormone) decreases, leading to overeating.
Even with Jardiance, poor sleep quality can cut your weight loss results in half. Aim for 6-8 hours of quality sleep per day, and limit late-night phone use, caffeine, and alcohol before bed. Chronic stress also increases cortisol secretion, promoting visceral fat accumulation, so light exercise and hobbies for stress relief are important.


Here are several typical progress patterns from patients who took Jardiance (ages and progressions are generalized from real cases for privacy).
Man in his 30s, baseline BMI 28.5, loved white rice and noodles, struggled with food restriction. Previously discontinued GLP-1 due to severe nausea.
For people for whom appetite suppressants don’t agree, Jardiance is often an easier option to continue.
Man in his 40s, baseline BMI 32, flagged for high blood glucose, blood pressure, and lipids on health checkup.
For obese patients aiming for substantial weight loss, combination with Rybelsus or Mounjaro under medical supervision is an option. However, risks also rise, so you must follow your doctor’s instructions.
Man in his 50s, baseline BMI 27, on medication for hypertension and dyslipidemia. Visited saying, “I want not just weight loss, but to lower cardiovascular risk.”
As shown in the EMPA-REG OUTCOME study, Jardiance’s strength is not only “weight loss” but also “protecting cardiovascular and renal function”. For management of obesity, this added value is significant.
Not everyone loses weight smoothly. Below are common failure patterns from cases that did not go as planned.
Knowing these failure patterns alone makes it easier to get the most out of Jardiance. When in doubt, always consult your doctor rather than self-managing.


In a Phase III trial, patients taking empagliflozin 25 mg for 24 weeks showed an average weight reduction of about 2.15 kg compared with placebo. Even greater weight loss has been observed in long-term trials, with a typical guideline of 2-5 kg of weight loss over 3-6 months. Individual results vary by carbohydrate intake and lifestyle, and outcomes are not guaranteed.
The basic rule is once daily in the morning. Absorption does not differ much before vs. after meals, but most clinics recommend after breakfast to prevent missed doses. Taking it around meals high in carbohydrates can excrete more glucose.
The main side effects are UTI, genital infection, frequent urination, dehydration, and dry mouth, most of which are mild to moderate. Drinking 1.5-2 L of fluids daily and maintaining genital hygiene prevents most issues. Serious side effects such as ketoacidosis, dehydration, and pyelonephritis exist, but their frequency is very low when fluid intake is maintained under medical supervision.
In terms of magnitude alone, Mounjaro currently shows greater weight loss (about 8-15 kg in 6 months). Jardiance’s typical 6-month range is about 3-5 kg. However, Jardiance has the unique strength of cardiovascular and renal protection, so the right choice depends on your goals and health status. For details, see our complete guide to Mounjaro.
Small amounts of alcohol are not immediately problematic, but heavy drinking raises the risk of dehydration, hypoglycemia, and ketoacidosis, so avoid it. A reasonable limit is about 1-2 medium bottles of beer or 2 glasses of wine. The morning after heavy drinking, you are likely dehydrated, so be sure to hydrate well before taking your dose.
When you stop Jardiance, the glucose-excretion effect ends, so weight tends to return if your diet and exercise stay the same as before. To prevent rebound, gradually adjust your eating volume and habits during treatment, and build an exercise routine. When ending treatment, work with your doctor to taper off step by step.
When prescribed for type 2 diabetes mellitus, chronic heart failure, or chronic kidney disease, Jardiance is covered by health insurance. However, when prescribed for medical weight loss, it is self-pay (out of pocket). Pricing varies by clinic, so we recommend confirming in advance. Men’s Care Clinic provides pricing information during free counseling.
Because weight loss appears gradually, the standard duration is at least 3 months, and 6-12 months if you have a target weight. It is not a drug that produces large weight loss in a single month, so it is not suitable for short-term goals. Long-term safety has been broadly confirmed in diabetes treatment, but ongoing follow-up with a doctor remains important.
Personal import is technically legal, but due to counterfeit risks, lack of damage relief, and missed contraindications, we strongly recommend obtaining it via a medical institution. Many counterfeits of SGLT2 inhibitors have been reported in overseas mail order. For safety, doctor prescription is the only reliable route.
Because they have different mechanisms of action, combination is possible under a doctor’s judgment, but hypoglycemia, dehydration, and ketoacidosis risk all increase, so management at a medical institution is required. The basic principle is to start with a single drug, observe response and side effects, and consider combination only if needed. For details, see our Rybelsus explanation page.
Moderate exercise is recommended. However, midsummer or long high-intensity workouts increase the risk of dehydration and hypoglycemia, so be diligent about fluid and salt intake. High-intensity exercise on an empty stomach is also a risk factor for ketoacidosis, so coordinate meal timing and hydration with your doctor.
References
This article was prepared under the supervision of the Men’s Care Clinic medical team, based on package inserts and Japanese and international clinical trial data. Information reflects the situation as of May 2026; please always check the latest package insert and guidelines. Actual prescriptions vary based on each patient’s individual condition.
肥満症
関連記事
2026/04/21 肥満症 【医師監修】内臓脂肪を落とす方法|隠れ肥満・メタボ診断・効果的な解消法を徹底解説
2026/04/11 肥満症 【医師監修】肥満症とは?男性の肥満の原因・リスク・医療ダイエット治療法を徹底解説
2026/03/31 肥満症 【医師監修】マンジャロ(チルゼパチド)とは?効果・副作用・費用をわかりやすく解説
2025/05/13 肥満症 満腹感を高め食事制限をサポート!ダイエット薬「リベルサス」
2022/12/13 肥満症 【医師監修】防風通聖散とは|効果・副作用・飲み方・男性のお腹脂肪対策
2022/12/13 肥満症 ジャディアンス(エンパグリフロジン)の効果と副作用|糖を排出する医療ダイエット薬を医師が徹底解説【2026年最新】
2026.04.21
肥満症
【医師監修】内臓脂肪を落とす方法|隠れ肥満・メタボ診断・効果的な解消法を徹底解説
2026.04.11
肥満症
【医師監修】肥満症とは?男性の肥満の原因・リスク・医療ダイエット治療法を徹底解説
2026.03.31
肥満症
【医師監修】マンジャロ(チルゼパチド)とは?効果・副作用・費用をわかりやすく解説
2025.05.13
肥満症
満腹感を高め食事制限をサポート!ダイエット薬「リベルサス」
2022.12.13
肥満症
【医師監修】防風通聖散とは|効果・副作用・飲み方・男性のお腹脂肪対策
2022.12.13
肥満症
ジャディアンス(エンパグリフロジン)の効果と副作用|糖を排出する医療ダイエット薬を医師が徹底解説【2026年最新】